SPAC · Merger completed
KINS Technology Group Inc.
Business combination with CXApp Holding Corp.
KINS Technology Group Inc. is a blank-check company (SPAC) that raised $240M in its initial public offering on Dec 16, 2020, listing on Nasdaq Capital Market. It completed its business combination with CXApp Holding Corp. on Mar 14, 2023; the combined company is CXApp Inc. (CXAI). Chief Executive Officer of Platial led the IPO, with Saia. Skadden, Arps advised the SPAC and Ropes & Gray advised the underwriters on the IPO.
CXApp Holding Corp. is a wholly owned subsidiary of Inpixon, offering Indoor Intelligence and mobile app solutions that deliver insights about people, places and things. Industries use them to optimize operations, increase productivity and enhance safety.
- Status
- Merger completed
- IPO date
- Dec 16, 2020
- IPO size
- $240M
- IPO exchange
- Nasdaq Capital Market
- Target
- CXApp Holding Corp. (Legacy CXApp, carved out of Inpixon)
- Announced
- Sep 26, 2022
- Closed
- Mar 14, 2023
- Combined company
- CXApp Inc. (CXAI)
- IPO underwriters
- Chief Executive Officer of Platial and Saia
- SPAC counsel (IPO)
- Skadden, Arps
- Underwriters' counsel (IPO)
- Ropes & Gray
More on this SPAC for subscribers
- Trust balance and value per share
- Redemptions at each extension and at the merger vote
- Liquidation deadline and extension history
- Merger proxy, registration statement and investor presentation
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Dec 16, 2020
- Deal announcement (8-K) Sep 26, 2022
- Press release
- All filings on EDGAR CIK 1820875
Other deSPACs that closed in 2023
- Near Intelligence, Inc.via KludeIn I Acquisition Corp · closed Mar 23, 2023
- Zura Bio Limitedvia JATT Acquisition Corp · closed Mar 20, 2023
- NioCorp Developments Ltd.via GX Acquisition Corp. II · closed Mar 17, 2023
- YS Biopharma Co., Ltd.via Summit Healthcare Acquisition Corp. · closed Mar 16, 2023
- Oculis Holding AGvia European Biotech Acquisition Corp. · closed Mar 8, 2023
- SMX (Security Matters) Public Limited Companyvia Lionheart III Corp · closed Mar 7, 2023